FOXD1 and nasopharyngeal carcinoma: We further validated these findings using qPCR on NPC specimens, demonstrating that FOXD1 mRNA levels were indeed elevated in tumor (T) tissues compared with non-tumor (N) tissues (Fig. 1A).